Skip to content
  • Reports
  • Podcast
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Novartis » Page 5

Novartis

ADVERTISEMENT
News and Trends

Results from 45% of Clinical Trials are kept Secret

A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the…

By Clara Rodríguez Fernández
07/11/2016 - 2 minutes
News and Trends

UPDATE: Future of CAR-T shaken by Novartis R&D Shuffle

After a promising kick off, Novartis is raising doubts about the future of its CAR-T…

By Evelyn Warner
27/10/2016 - 3 minutes
News and Trends

Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment

GeNeuro is developing a unique treatment for multiple sclerosis. We interviewed Miguel Payro, the company's CFO, who…

By Clara Rodríguez Fernández
30/09/2016 - 1 minute
News and Trends

Debunking the Immuno-Oncology Hype: is it as good as it sounds?

CAR-T therapies have gained plenty of attention lately by promising to end cancer with a one-off…

By Clara Rodríguez Fernández
29/09/2016 - 5 minutes
News and Trends

UPDATE: Novartis is Favoured to Win the Race for a New MS Drug

Novartis is poised to kick off the next generation of multiple sclerosis treatments after siponimod performs…

By Evelyn Warner
20/09/2016 - 2 minutes
News and Trends

Novartis invests in Irish Upstart tackling Chronic Inflammation

Dublin-based Inflazome has made a splashy debut by closing Series A with €15M. The company…

By Evelyn Warner
14/09/2016 - 2 minutes
News and Trends

UPDATED: Storm on the CAR-T field – 3 patients die in Phase II Study

A CAR-T program in Phase II trials (from Juno Therapeutics) was suspended by the FDA…

By Denise Neves Gameiro
18/07/2016 - 5 minutes
News and Trends

Novartis delivers German Biotech’s 12th Antibody to Clinics

MorphoSys keeps up its impressive productivity in feeding pipelines. Its 12th antibody in its Novartis…

By Denise Neves Gameiro
04/07/2016 - 2 minutes
News and Trends

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

MorphoSys confirms that its antibody (bimagrumab) failed to meet the primary endpoint of a phase…

By Denise Neves Gameiro
27/04/2016 - 2 minutes
News and Trends

Cancer: World Best Ever CAR-T Results have Just been Disclosed

These are the best results yet for CAR-T, this time from a research group led by…

By Denise Neves Gameiro
17/02/2016 - 3 minutes
News and Trends

The European Union Finances the Future of CAR-T Manufacturing

CAR-T is the way forward in Cancer therapeutics, which is one of the leading causes…

By Dani Bancroft
08/02/2016 - 3 minutes
News and Trends

World CAR-T Leader Starts New Program with a UK Biotech

Pretty impressive CAR-T news coming from across the Channel... Oxford BioMedica just launched a second…

By Philip Hemme
01/02/2016 - 2 minutes
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Startups Gene therapy Synthetic biology
    Labiotech.eu
    Log In Newsletter

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast